Oxytocin

Generic Name
Oxytocin
Brand Names
Pitocin
Drug Type
Biotech
Chemical Formula
-
CAS Number
50-56-6
Unique Ingredient Identifier
1JQS135EYN
Background

Sir Henry H. Dale first identified oxytocin and its uterine contractile properties in 1906. Like all other neurohypophysial hormones, oxytocin is composed of nine amino acids with a disulfide bridge between the Cys 1 and 6 residues. In the mid-1950s, synthetic oxytocin was successfully synthesized by a biochemist named Vincent du Vigneaud; he was later recog...

Indication

Administration of exogenous oxytocin is indicated in the antepartum period to initiate or improve uterine contractions for vaginal delivery in situations where there is fetal or maternal concern. For example, It may be used to induce labor in cases of Rh sensitization, maternal diabetes, preeclampsia at or near term, and when delivery is indicated due to pre...

Associated Conditions
Incomplete Abortion, Inevitable abortion, Postpartum Bleeding
Associated Therapies
Reinforcement of labor

Effects of Oxytocin Nasal Spray on Social Affiliation

Phase 2
Completed
Conditions
Interventions
First Posted Date
2008-04-21
Last Posted Date
2019-09-09
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
27
Registration Number
NCT00663039
Locations
🇺🇸

Maryland Psychiatric Research Center, Catonsville, Maryland, United States

Is Oxytocin Given During Surgical Procedure for Abortion Before 12 Weeks of Pregnancy Useful?

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2007-10-08
Last Posted Date
2010-04-16
Lead Sponsor
Asker & Baerum Hospital
Target Recruit Count
400
Registration Number
NCT00540748
Locations
🇳🇴

Kvinneklinikken SABHF, Baerum, Rud, Norway

Oxytocin Add on Study for Stable Schizophrenic Patients

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2007-07-25
Last Posted Date
2019-09-25
Lead Sponsor
David Feifel
Target Recruit Count
21
Registration Number
NCT00506909
Locations
🇺🇸

University of California San Diego, San Diego, California, United States

Intranasal Oxytocin in the Treatment of Autism

Phase 2
Completed
Conditions
Interventions
First Posted Date
2007-06-25
Last Posted Date
2015-10-23
Lead Sponsor
Evdokia Anagnostou
Target Recruit Count
19
Registration Number
NCT00490802
Locations
🇺🇸

Mount Sinai School of Medicine, New York, New York, United States

Ergot and Oxytocin During Cesarean Delivery Following Failure to Progress in Labour

Not Applicable
Completed
Conditions
First Posted Date
2007-06-01
Last Posted Date
2007-06-01
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
47
Registration Number
NCT00481533
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Active Versus Expectant Management of the Third Stage of Labor

First Posted Date
2007-05-15
Last Posted Date
2023-04-12
Lead Sponsor
Christiana Care Health Services
Target Recruit Count
218
Registration Number
NCT00473707
Locations
🇺🇸

Christiana Care Health System, Newark, Delaware, United States

A Randomized, Control Trial for Preinduction Cervical Ripening

Phase 2
Completed
Conditions
First Posted Date
2006-10-29
Last Posted Date
2008-01-16
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
540
Registration Number
NCT00393731
Locations
🇺🇸

Lyndon B. Johnson Hospital, Houston, Texas, United States

Oxytocin Effects on Cytokines and Endocrine Parameters After LPS Induced Systemic Inflammatory Effects in Healthy Volunteers

Completed
Conditions
First Posted Date
2006-08-03
Last Posted Date
2007-12-11
Lead Sponsor
Medical University of Vienna
Target Recruit Count
10
Registration Number
NCT00360048
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism

Phase 1
Completed
Conditions
Interventions
First Posted Date
2005-12-09
Last Posted Date
2014-04-30
Lead Sponsor
Anagnostou, Evdokia, M.D.
Target Recruit Count
16
Registration Number
NCT00263796
Locations
🇺🇸

Mount Sinai School of Medicine, New York, New York, United States

Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section?

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2005-11-23
Last Posted Date
2014-03-17
Lead Sponsor
University of British Columbia
Target Recruit Count
150
Registration Number
NCT00257803
Locations
🇨🇦

BC Women's Hospital, Department of Anesthesia, Vancouver, British Columbia, Canada

© Copyright 2024. All Rights Reserved by MedPath